Molecubes PET/CT system
Molecubes PET/CT 系统
基本信息
- 批准号:10428308
- 负责人:
- 金额:$ 59.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-01 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:AnimalsBiomedical ResearchComputed Tomography ScannersCore FacilityCyclotronsDevicesDisease ProgressionEmission-Computed TomographyEnsureEquipmentFundingFutureGenerationsHigh Resolution Computed TomographyImageInfrastructureInstitutionIntuitionIsotopesMagnetic Resonance ImagingMedical centerMinorMonitorPositron-Emission TomographyProductionRadiationRadiation PhysicsRadiation exposureRadiochemistryRequest for ProposalsResearchResearch InstituteResearch PersonnelResource SharingScanningServicesSmall Animal Imaging SystemsSystemTechniquesTechnologyTexasTracerUnited States National Institutes of HealthUniversitiesX-Ray Computed Tomographyanimal facilityanimal imagingcancer preventioncostdesigngerm free conditionimage guidedimaging capabilitiesimaging modalityimprovedin vivo imaginginstrumentlight weightmultimodalitynoveloperationoptical imagingpre-clinicalpre-clinical researchprogramsradiation deliveryuser-friendly
项目摘要
ABSTRACT
This proposal requests funds to acquire a new state-of-the-art MOLECUBES small animal imaging system with
Positron Emission Tomography (PET) and Computed Tomography (CT) capabilities to support pre-clinical
research at the University of Texas Southwestern Medical Center (UTSW). This multi-modality system includes
the highest sensitivity PET system commercially available and a high-resolution CT for routine animal imaging
with low radiation exposure. This equipment is selected compared to other commercially available scanners,
also because of its compact size and light weight, user-friendly interface and intuitive workflow, high-
throughput imaging capability, modular design enabling future expandability, as well as compatibility with other
existing devices. UTSW has a long and successful record of accomplishment in conducting ground-breaking
biomedical research. Many projects significantly benefit from in vivo imaging to acquire structural and
functional information. Especially with the establishment of Cyclotron and Radiochemistry Program offering
onsite production of novel PET tracers, a UTSW program funded by the Cancer Prevention and Research
Institute of Texas (CPRIT), desire for pre-clinical PET/CT imaging has been growing substantially because of
more scanning opportunities, access to short-lived isotopes, more types of isotopes for expanded research
endeavors, and reduced costs associated with isotope transport from elsewhere. Nonetheless, currently there
is only one PET/CT scanner in UTSW, which employed older-generation PET/CT technologies and cannot
meet the technical needs in imaging quality and scanning efficiency. More critically, this scanner is located
outside the Specific-pathogen-free animal facility, substantially limiting scope of projects behind the animal
barrier, e.g. those using immuno-deficient animals, and prohibiting studies requiring multiple PET/CT scans,
e.g. for longitudinally monitoring disease progression. The requested PET/CT will be installed in and managed
by PreClinical Radition Core Facility (PCRCF) of UTSW located behind the animal barrier, a CPRIT-funded
shared resource facility for in vivo imaging and radiation technologies and services. This setting allows
maximally taking advantages of existing instrument and management infrastructure of the PCRCF to provide
users a one-stop solution to access all major imaging modalities (PET/CT/MR/Optical imaging) and radiation
delivery techniques (image-guided small animal irradiator), as well as extensive imaging and radiation physics
expertise. To demonstrate the need for the requested PET/CT, we have assembled Major and Minor user
groups. Their diverse spectrum of projects, majority of which funded by the NIH, ensures adequate use of the
equipment. We have formed an Advisory Board to oversee the PET/CT operation and developed a sustainable
financial plan. The requested instrument will meet a significant need of our institution for state-of-the-art in vivo
imaging behind the animal barrier. It will improve accuracy and efficiency of projects it supports, as well as
open new opportunities for our investigators.
抽象的
该提案要求资金购买一种新的最先进的 MOLECUBES 小动物成像系统
正电子发射断层扫描 (PET) 和计算机断层扫描 (CT) 功能支持临床前
德克萨斯大学西南医学中心(UTSW)的研究。这个多模态系统包括
市售最高灵敏度 PET 系统和用于常规动物成像的高分辨率 CT
辐射暴露量低。与其他市售扫描仪相比,选择此设备,
还因其尺寸紧凑、重量轻、用户友好的界面和直观的工作流程,高
吞吐量成像能力、模块化设计可实现未来的可扩展性以及与其他设备的兼容性
现有设备。 UTSW 在开展突破性的项目方面拥有长期成功的记录
生物医学研究。许多项目显着受益于体内成像来获取结构和
功能信息。特别是随着回旋加速器和放射化学课程的建立
现场生产新型 PET 示踪剂,这是由癌症预防和研究资助的 UTSW 项目
德克萨斯研究所 (CPRIT),由于以下原因,对临床前 PET/CT 成像的需求大幅增长
更多扫描机会、获得短寿命同位素、更多类型的同位素用于扩展研究
努力,并降低与从其他地方运输同位素相关的成本。尽管如此,目前有
是 UTSW 仅有的一台 PET/CT 扫描仪,它采用了老一代 PET/CT 技术,无法
满足成像质量和扫描效率的技术需求。更关键的是,这个扫描仪位于
在无特定病原体的动物设施之外,大大限制了动物背后的项目范围
障碍,例如使用免疫缺陷动物,并禁止需要多次 PET/CT 扫描的研究,
例如用于纵向监测疾病进展。所请求的 PET/CT 将安装并管理
由位于动物屏障后面的 UTSW 临床前放射核心设施 (PCRCF) 进行,这是一个由 CPRIT 资助的项目
体内成像和辐射技术和服务的共享资源设施。此设置允许
最大限度地利用PCRCF现有的仪器和管理基础设施来提供
为用户提供访问所有主要成像模式(PET/CT/MR/光学成像)和辐射的一站式解决方案
传递技术(图像引导小动物辐照器),以及广泛的成像和辐射物理学
专业知识。为了证明对所要求的 PET/CT 的需求,我们聚集了主要和次要用户
组。他们的项目多种多样,其中大部分由 NIH 资助,确保充分利用
设备。我们成立了一个顾问委员会来监督 PET/CT 运营,并制定了可持续发展计划
财务计划。所需的仪器将满足我们机构对最先进的体内技术的重大需求
动物屏障后面的成像。它将提高其支持的项目的准确性和效率,以及
为我们的调查人员提供新的机会。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Weiguo Lu其他文献
Weiguo Lu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Weiguo Lu', 18)}}的其他基金
Novel On-line PET Based Intra-Beam Range Verification and Delivery Optimization for Improved Particle Radiation Therapy
基于新型在线 PET 的束内范围验证和传输优化,以改进粒子放射治疗
- 批准号:
10355422 - 财政年份:2018
- 资助金额:
$ 59.99万 - 项目类别:
相似国自然基金
生物医学跨本体术语相似度方法及其在B细胞非霍奇金淋巴瘤中的应用研究
- 批准号:62372276
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
面向生物医学文本的知识自动总结研究
- 批准号:72304189
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
水凝胶光纤氧气传感关键问题研究及在生物医学中的应用
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
面向生物医学领域的多模态学术图像不端检测技术研究
- 批准号:
- 批准年份:2022
- 资助金额:53 万元
- 项目类别:面上项目
金属配位诱导的靶向蛋白降解平台的构建及生物医学应用研究
- 批准号:22277141
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
相似海外基金
Multimodality PET/CT Scanner for Small Animal Imaging
用于小动物成像的多模态 PET/CT 扫描仪
- 批准号:
10429458 - 财政年份:2022
- 资助金额:
$ 59.99万 - 项目类别:
MIRDCalc – A Community Tool for Deriving and Reporting Patient Organ Doses in Nuclear Medicine, Computed Tomography, and Hybrid Imaging
MIRDCalc — 用于导出和报告核医学、计算机断层扫描和混合成像中患者器官剂量的社区工具
- 批准号:
10456116 - 财政年份:2019
- 资助金额:
$ 59.99万 - 项目类别:
MIRDCalc – A Community Tool for Deriving and Reporting Patient Organ Doses in Nuclear Medicine, Computed Tomography, and Hybrid Imaging
MIRDCalc — 用于导出和报告核医学、计算机断层扫描和混合成像中患者器官剂量的社区工具
- 批准号:
10017971 - 财政年份:2019
- 资助金额:
$ 59.99万 - 项目类别:
MIRDCalc – A Community Tool for Deriving and Reporting Patient Organ Doses in Nuclear Medicine, Computed Tomography, and Hybrid Imaging
MIRDCalc — 用于导出和报告核医学、计算机断层扫描和混合成像中患者器官剂量的社区工具
- 批准号:
10696129 - 财政年份:2019
- 资助金额:
$ 59.99万 - 项目类别:
MIRDCalc – A Community Tool for Deriving and Reporting Patient Organ Doses in Nuclear Medicine, Computed Tomography, and Hybrid Imaging
MIRDCalc — 用于导出和报告核医学、计算机断层扫描和混合成像中患者器官剂量的社区工具
- 批准号:
10200807 - 财政年份:2019
- 资助金额:
$ 59.99万 - 项目类别: